CardioNet Inc
WebsiteVisit Company Website
HeadQuarterMalvern, PA, US
Founded1999
Company Size500 to 999 employees
IndustryBiotechnology/Pharmaceuticals
About CardioNet Inc
Overview
CardioNet has developed an integrated technology and service - Mobile Cardiac Outpatient Telemetry™ (MCOT™) - which enables heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365.
CardioNet is focused on helping physicians diagnose and treat patients with arrhythmias.
Time is of the essence in diagnosing and treating arrhythmias. Delays can lead to increased morbidity and mortality and cause significant anxiety for patients. But rapidly diagnosing and effectively treating patients with arrhythmia can be challenging.
Some arrhythmias occur too infrequently to be detected through 24-48 hours of Holter monitoring. Event recorders pose problems with asymptomatic patients and those who have difficulty triggering monitoring equipment. Correlating events with symptoms is often difficult.
CardioNet offers physicians a powerful diagnostic and patient management tool to address these challenges.
Company
Headquartered in Pennsylvania, CardioNet became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient Telemetry™ (MCOT™) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Mission Statement, Vision, and Values
Mission:
Providing better information to improve human health
Vision:
To be the world leader in wireless medicine and the delivery of health information by providing products and services that will improve quality of life and reduce cost of care
Values:
CardioNet has developed an integrated technology and service - Mobile Cardiac Outpatient Telemetry™ (MCOT™) - which enables heartbeat-by-heartbeat, ECG monitoring, analysis and response, at home or away, 24/7/365.
CardioNet is focused on helping physicians diagnose and treat patients with arrhythmias.
Time is of the essence in diagnosing and treating arrhythmias. Delays can lead to increased morbidity and mortality and cause significant anxiety for patients. But rapidly diagnosing and effectively treating patients with arrhythmia can be challenging.
Some arrhythmias occur too infrequently to be detected through 24-48 hours of Holter monitoring. Event recorders pose problems with asymptomatic patients and those who have difficulty triggering monitoring equipment. Correlating events with symptoms is often difficult.
CardioNet offers physicians a powerful diagnostic and patient management tool to address these challenges.
Company
Headquartered in Pennsylvania, CardioNet became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet Mobile Cardiac Outpatient Telemetry™ (MCOT™) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Mission Statement, Vision, and Values
Mission:
Providing better information to improve human health
Vision:
To be the world leader in wireless medicine and the delivery of health information by providing products and services that will improve quality of life and reduce cost of care
Values:
- We will create an environment that inspires creativity, innovation and personal growth
- We will treat each other with respect and dignity
- We will deliver the highest possible quality/value proposition to patients, physicians, other care providers, and payors
- We will grow profitably at a rate faster than the markets in selected segments
- We will always operate in a highly ethical and legally compliant fashion